Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maisonneuve

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Atlanta Medical and Surgical Journal|July 13, 2022
Total Ablation of the Inferior Maxilla, Executed with SuccessM Maisonneuve
Pharmacology, Biochemistry, and Behavior|August 5, 2003
Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatmentIsabelle M Maisonneuve, Stanley D Glick
Presse Medicale (Paris, France : 1983)|December 12, 1987
[Carcinoid tumors of the thymus. 2 cases]M Chambon, M Maisonneuve, B Guibert
Neuroreport|April 20, 1999
(+/-)Cyclazocine blocks the dopamine response to nicotineI M Maisonneuve, S D Glick
Annals of the New York Academy of Sciences|July 27, 2000
Development of novel medications for drug addiction. The legacy of an African shrubS D Glick, I M Maisonneuve
European Journal of Pharmacology|November 11, 1999
Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridineI M Maisonneuve, S D Glick
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis studyI M Maisonneuve, M J Kreek
Annals of the New York Academy of Sciences|November 2, 2017
Mechanisms of Antiaddictive Actions of Ibogaine<sup>a</sup>Stanley D Glick, Isabelle M Maisonneuve
European Journal of Pharmacology|March 3, 1992
Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behaviorI M Maisonneuve, S D Glick
Neuroscience Letters|November 7, 1994
U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of ratsI M Maisonneuve, S Archer, S D Glick
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Atlanta Medical and Surgical Journal|July 13, 2022
Total Ablation of the Inferior Maxilla, Executed with SuccessM Maisonneuve
Pharmacology, Biochemistry, and Behavior|August 5, 2003
Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatmentIsabelle M Maisonneuve, Stanley D Glick
Presse Medicale (Paris, France : 1983)|December 12, 1987
[Carcinoid tumors of the thymus. 2 cases]M Chambon, M Maisonneuve, B Guibert
Neuroreport|April 20, 1999
(+/-)Cyclazocine blocks the dopamine response to nicotineI M Maisonneuve, S D Glick
Annals of the New York Academy of Sciences|July 27, 2000
Development of novel medications for drug addiction. The legacy of an African shrubS D Glick, I M Maisonneuve
European Journal of Pharmacology|November 11, 1999
Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridineI M Maisonneuve, S D Glick
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis studyI M Maisonneuve, M J Kreek
Annals of the New York Academy of Sciences|November 2, 2017
Mechanisms of Antiaddictive Actions of Ibogaine<sup>a</sup>Stanley D Glick, Isabelle M Maisonneuve
European Journal of Pharmacology|March 3, 1992
Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behaviorI M Maisonneuve, S D Glick
Neuroscience Letters|November 7, 1994
U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of ratsI M Maisonneuve, S Archer, S D Glick
Pageof 9